Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Nov;33(11):3047–3048. doi: 10.1128/jcm.33.11.3047-3048.1995

Case of recurrent Flavimonas oryzihabitans bacteremia associated with an implanted central venous catheter (Port-A-Cath): assessment of clonality by arbitrarily primed PCR.

B Verhasselt 1, G Claeys 1, A Elaichouni 1, G Verschraegen 1, G Laureys 1, M Vaneechoutte 1
PMCID: PMC228635  PMID: 8576374

Abstract

Flavimonas oryzihabitans bacteremias, which occurred immediately after the flushing or use of an implanted central venous catheter (Port-A-Cath) in two patients at the same pediatric ward, were studied by arbitrarily primed PCR. We conclude that the colonization of the Port-A-Cath with F. oryzihabitans described here lasted for several months.

Full Text

The Full Text of this article is available as a PDF (191.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elaichouni A., Verschraegen G., Claeys G., Devleeschouwer M., Godard C., Vaneechoutte M. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol. 1994 Mar;32(3):666–671. doi: 10.1128/jcm.32.3.666-671.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Harvey W. H., Pick T. E., Reed K., Solenberger R. I. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet. 1989 Dec;169(6):495–500. [PubMed] [Google Scholar]
  3. Lucas K. G., Kiehn T. E., Sobeck K. A., Armstrong D., Brown A. E. Sepsis caused by Flavimonas oryzihabitans. Medicine (Baltimore) 1994 Jul;73(4):209–214. doi: 10.1097/00005792-199407000-00003. [DOI] [PubMed] [Google Scholar]
  4. Mueller B. U., Skelton J., Callender D. P., Marshall D., Gress J., Longo D., Norton J., Rubin M., Venzon D., Pizzo P. A. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol. 1992 Dec;10(12):1943–1948. doi: 10.1200/JCO.1992.10.12.1943. [DOI] [PubMed] [Google Scholar]
  5. Rahav G., Simhon A., Mattan Y., Moses A. E., Sacks T. Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2). Medicine (Baltimore) 1995 Mar;74(2):83–88. doi: 10.1097/00005792-199503000-00003. [DOI] [PubMed] [Google Scholar]
  6. Romanyk J., Gonzalez-Palacios R., Nieto A. A new case of bacteraemia due to Flavimonas oryzihabitans. J Hosp Infect. 1995 Mar;29(3):236–237. doi: 10.1016/0195-6701(95)90336-4. [DOI] [PubMed] [Google Scholar]
  7. Welsh J., McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res. 1990 Dec 25;18(24):7213–7218. doi: 10.1093/nar/18.24.7213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wesenberg F., Flaatten H., Janssen C. W., Jr Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children. Pediatr Hematol Oncol. 1993 Jul-Sep;10(3):233–239. doi: 10.3109/08880019309029489. [DOI] [PubMed] [Google Scholar]
  9. Williams J. G., Kubelik A. R., Livak K. J., Rafalski J. A., Tingey S. V. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 1990 Nov 25;18(22):6531–6535. doi: 10.1093/nar/18.22.6531. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES